TIDMMXC
RNS Number : 0035Z
MGC Pharmaceuticals Limited
10 May 2023
MGC Pharmaceuticals Ltd.
PDMR Notification
10 May 2023
ASX, LSE: MXC
MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') wishes
to advise that the following Persons Discharging Managerial
Responsibilities (PDMR) have dealt with shares in MGC Pharma, and
this notification is made in accordance the UK Market Abuse
Regulations.
The shares subject of this notice were issued to the PDMR as
part of their working contracts and as consideration for services
rendered in lieu of cash payments. In addition to the issue, there
was also a disposal of shares by one PDMR.
Following the issue of these shares, the Company has
3,349,692,950 ordinary shares in issue, each with one voting right.
Therefore, the Company's total number of ordinary shares in issue
and voting rights is 3,349,692,950 and this figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Amir Polak
--------------------------------------- -----------------------------------
2 Reason for the notification
----------------------------------------------------------------------------
(a) Position Chief Pharmaceutical Development
Officer
--------------------------------------- -----------------------------------
(b) Initial notification/amendment Initial
--------------------------------------- -----------------------------------
(c) If amendment: reason n/a
--------------------------------------- -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
--------------------------------------- -----------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
--------------------------------------- -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
--------------------------------------- -----------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
--------------------------------------- -----------------------------------
(c) Nature of transaction Disposal of shares
--------------------------------------- -----------------------------------
(d) Currency Price Volume Total
------------------ ------------------- ------------- --------------------
AUD $0.008 500,000 $4,000
------------------------ ------------------- ------------- --------------------
Aggregated information
----------------------------------------------------------------------------
AUD $0.008 500,000 $4,000
------------------------ ------------------- ------------- --------------------
(e) Date of transaction 1. 2023-05-04
--------------------------------------- -----------------------------------
(f) Place of transaction Australian Stock Exchange
--------------------------------------- -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
--------------------------------------- -----------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
--------------------------------------- -----------------------------------
(c) Nature of transaction Shares issued as consideration
for services rendered
--------------------------------------- -----------------------------------
(d) Currency Price Volume Total
------------------ ------------------- ------------- --------------------
AUD $0.0107 7,209,112 $77,137
------------------------ ------------------- ------------- --------------------
Aggregated information
----------------------------------------------------------------------------
AUD $0.0107 7,209,112 $77,137
------------------------ ------------------- ------------- --------------------
(e) Date of transaction 2023-05-05
--------------------------------------- -----------------------------------
(f) Place of transaction Outside a trading venue
--------------------------------------- -----------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Itay Nissim
--------------------------------------- -----------------------------------
2 Reason for the notification
----------------------------------------------------------------------------
(a) Position Chief Manufacturing and Supply
Chain Officer
--------------------------------------- -----------------------------------
(b) Initial notification/amendment Initial
--------------------------------------- -----------------------------------
(c) If amendment: reason n/a
--------------------------------------- -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
--------------------------------------- -----------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
--------------------------------------- -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
--------------------------------------- -----------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
--------------------------------------- -----------------------------------
(c) Nature of transaction Shares issued as consideration
for services rendered.
--------------------------------------- -----------------------------------
(d) Currency Price Volume Total
------------------ ------------------- ------------- --------------------
AUD $0.0107 6,946,963 $74,333
------------------------ ------------------- ------------- --------------------
Aggregated information
----------------------------------------------------------------------------
AUD $0.0107 6,946,963 $74,333
------------------------ ------------------- ------------- --------------------
(e) Date of transaction 2023-05-05
--------------------------------------- -----------------------------------
(f) Place of transaction Outside a trading venue
--------------------------------------- -----------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Robert Clements
--------------------------------------- -----------------------------------
2 Reason for the notification
----------------------------------------------------------------------------
(a) Position Chief Commercial Officer
--------------------------------------- -----------------------------------
(b) Initial notification/amendment Initial
--------------------------------------- -----------------------------------
(c) If amendment: reason n/a
--------------------------------------- -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
--------------------------------------- -----------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
--------------------------------------- -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
--------------------------------------- -----------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
--------------------------------------- -----------------------------------
(c) Nature of transaction Shares issued as consideration
for services rendered.
--------------------------------------- -----------------------------------
(d) Currency Price Volume Total
------------------ ------------------- ------------- --------------------
AUD $0.0107 7,537,673 $80,653
------------------------ ------------------- ------------- --------------------
Aggregated information
----------------------------------------------------------------------------
AUD $0.0107 7,537,673 $80,653
------------------------ ------------------- ------------- --------------------
(e) Date of transaction 2023-05-05
--------------------------------------- -----------------------------------
(f) Place of transaction Outside a trading venue
--------------------------------------- -----------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Tom Cairns
--------------------------------------- -----------------------------------
2 Reason for the notification
----------------------------------------------------------------------------
(a) Position Chief Accounting Officer
--------------------------------------- -----------------------------------
(b) Initial notification/amendment Initial
--------------------------------------- -----------------------------------
(c) If amendment: reason n/a
--------------------------------------- -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
--------------------------------------- -----------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
--------------------------------------- -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
--------------------------------------- -----------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
--------------------------------------- -----------------------------------
(c) Nature of transaction Shares issued as consideration
for services rendered.
--------------------------------------- -----------------------------------
(d) Currency Price Volume Total
------------------ ------------------- ------------- --------------------
AUD $0.0107 6,408,682 $68,573
------------------------ ------------------- ------------- --------------------
Aggregated information
----------------------------------------------------------------------------
AUD $0.0107 6,408,682 $68,573
------------------------ ------------------- ------------- --------------------
(e) Date of transaction 2023-05-05
--------------------------------------- -----------------------------------
(f) Place of transaction Outside a trading venue
--------------------------------------- -----------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Yifat Steuer
--------------------------------------- -------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------
(a) Position Chief Operating Officer and Deputy
CEO
--------------------------------------- -------------------------------------
(b) Initial notification/amendment Initial
--------------------------------------- -------------------------------------
(c) If amendment: reason n/a
--------------------------------------- -------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
--------------------------------------- -------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
--------------------------------------- -------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
--------------------------------------- -------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
--------------------------------------- -------------------------------------
(c) Nature of transaction Shares issued as consideration
for services rendered.
--------------------------------------- -------------------------------------
(d) Currency Price Volume Total
------------------ ------------------- -------------- ---------------------
AUD $0.0107 11,359,813 $121,550
------------------------ ------------------- -------------- ---------------------
Aggregated information
------------------------------------------------------------------------------
AUD $0.0107 11,359,813 $121,550
------------------------ ------------------- -------------- ---------------------
(e) Date of transaction 2023-05-05
--------------------------------------- -------------------------------------
(f) Place of transaction Outside a trading venue
--------------------------------------- -------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Yair Tal
--------------------------------------- -------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------
(a) Position Chief Information Security Officer
--------------------------------------- -------------------------------------
(b) Initial notification/amendment Initial
--------------------------------------- -------------------------------------
(c) If amendment: reason n/a
--------------------------------------- -------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
--------------------------------------- -------------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
--------------------------------------- -------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
--------------------------------------- -------------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
--------------------------------------- -------------------------------------
(c) Nature of transaction Shares issued as consideration
for services rendered.
--------------------------------------- -------------------------------------
(d) Currency Price Volume Total
------------------ ------------------- -------------- ---------------------
AUD $0.0107 7,078,038 $75,732
------------------------ ------------------- -------------- ---------------------
Aggregated information
------------------------------------------------------------------------------
AUD $0.0107 7,078,038 $75,732
------------------------ ------------------- -------------- ---------------------
(e) Date of transaction 2023-05-05
--------------------------------------- -------------------------------------
(f) Place of transaction Outside a trading venue
--------------------------------------- -------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
(a) Name Nicole Godress
--------------------------------------- -----------------------------------
2 Reason for the notification
----------------------------------------------------------------------------
(a) Position Global Chief Sales Officer MGC
Medical
--------------------------------------- -----------------------------------
(b) Initial notification/amendment Initial
--------------------------------------- -----------------------------------
(c) If amendment: reason n/a
--------------------------------------- -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------
Full name of entity MGC Pharmaceuticals Limited
--------------------------------------- -----------------------------------
Legal Entity Identifier 213800HRE3FQJ6RK4H10
Code
--------------------------------------- -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
(a) Description of the financial Fully Paid Ordinary Shares
instrument, type of
instrument
--------------------------------------- -----------------------------------
(b) Identification Code AU000000MXC6
(ISIN)
--------------------------------------- -----------------------------------
(c) Nature of transaction Shares issued as consideration
for services rendered.
--------------------------------------- -----------------------------------
(d) Currency Price Volume Total
------------------ ------------------- ------------- --------------------
AUD $0.0107 876,636 $9,380
------------------------ ------------------- ------------- --------------------
Aggregated information
----------------------------------------------------------------------------
AUD $0.0107 876,636 $9,380
------------------------ ------------------- ------------- --------------------
(e) Date of transaction 2023-05-05
--------------------------------------- -----------------------------------
(f) Place of transaction Outside a trading venue
--------------------------------------- -----------------------------------
--Ends--
Authorised for release by the Managing Director, for further
information please contact:
MGC Pharmaceuticals Ltd MGC Pharmaceuticals Ltd
Roby Zomer Arron Canicais / Rowan Harland
CEO & Managing Director Joint Company Secretaries
+61 8 6382 3390 +61 8 6382 3390
info@mgcpharma.co.uk info@mgcpharma.co.uk
UK PR Advisors UK Brokers
Tavistock Peterhouse Capital
Charles Vivian / Tim Pearson Charles Goodfellow / Lucy Williams
+44 207 920 3150 +44 207 469 0930
mgcpharma@tavistock.co.uk cg@peterhousecap.com / lw@peterhousecap.com
UK Financial and Corporate Advisor
SW4 Partners
Rupert Fane / Nilesh Patel
rupert@sw4partners.com / nilesh@sw4partners.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBLGDUDGBDGXG
(END) Dow Jones Newswires
May 10, 2023 12:05 ET (16:05 GMT)
Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Mgc Pharmaceuticals (LSE:MXC)
Historical Stock Chart
From Oct 2023 to Oct 2024
